Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets
KA Jacobson, AP IJzerman, CE Müller - Biochemical pharmacology, 2021 - Elsevier
Abstract Prof. Geoffrey Burnstock originated the concept of purinergic signaling. He
demonstrated the interactions and biological roles of ionotropic P2X and metabotropic P2Y …
demonstrated the interactions and biological roles of ionotropic P2X and metabotropic P2Y …
In silico drug design for purinergic GPCRs: overview on molecular dynamics applied to adenosine and P2Y receptors
V Salmaso, KA Jacobson - Biomolecules, 2020 - mdpi.com
Molecular modeling has contributed to drug discovery for purinergic GPCRs, including
adenosine receptors (ARs) and P2Y receptors (P2YRs). Experimental structures and …
adenosine receptors (ARs) and P2Y receptors (P2YRs). Experimental structures and …
Discovery of P2Y2 Receptor Antagonist Scaffolds through Virtual High-Throughput Screening
A Neumann, I Attah, H Al-Hroub… - Journal of chemical …, 2022 - ACS Publications
The human ATP-and UTP-activated P2Y2 receptor (P2Y2R) is a Gq protein-coupled
receptor involved in several pathophysiological conditions including acute and chronic …
receptor involved in several pathophysiological conditions including acute and chronic …
Machine learning-aided search for ligands of P2Y6 and other P2Y receptors
The P2Y6 receptor, activated by uridine diphosphate (UDP), is a target for antagonists in
inflammatory, neurodegenerative, and metabolic disorders, yet few potent and selective …
inflammatory, neurodegenerative, and metabolic disorders, yet few potent and selective …
Double-modified, thio and methylene ATP analogue facilitates wound healing in vitro and in vivo
R Pawlowska, E Radzikowska-Cieciura, S Jafari… - Scientific Reports, 2024 - nature.com
Recent data indicate that extracellular ATP affects wound healing efficacy via P2Y2-
dependent signaling pathway. In the current work, we propose double-modified ATP …
dependent signaling pathway. In the current work, we propose double-modified ATP …
Potent, Selective Agonists for the Cannabinoid-like Orphan G Protein-Coupled Receptor GPR18: A Promising Drug Target for Cancer and Immunity
AB Mahardhika, M Załuski, CT Schoeder… - Journal of Medicinal …, 2024 - ACS Publications
The human orphan G protein-coupled receptor GPR18, activated by Δ9-
tetrahydrocannabinol (THC), constitutes a promising drug target in immunology and cancer …
tetrahydrocannabinol (THC), constitutes a promising drug target in immunology and cancer …
Nucleic acid ligands act as a PAM and agonist depending on the intrinsic ligand binding state of P2RY2
M Takahashi, R Amano, M Ozawa… - Proceedings of the …, 2021 - National Acad Sciences
G protein–coupled receptors (GPCRs) play diverse roles in physiological processes, and
hence the ligands to modulate GPCRs have served as important molecules in biological and …
hence the ligands to modulate GPCRs have served as important molecules in biological and …
G protein coupled P2Y2 receptor as a regulatory molecule in cancer progression
W Zhang, Q Shi, T Li, Y Huang - Archives of Biochemistry and Biophysics, 2024 - Elsevier
The occurrence and development of cancer involves the participation of many factors, its
pathological mechanism is far more complicated than other diseases, and the treatment is …
pathological mechanism is far more complicated than other diseases, and the treatment is …
The P2Y2 Receptor C-Terminal Tail Modulates but Is Dispensable for β-Arrestin Recruitment
The P2Y2 receptor (P2Y2R) is a G protein-coupled receptor that is activated by extracellular
ATP and UTP, to a similar extent. This allows it to play roles in the cell's response to the …
ATP and UTP, to a similar extent. This allows it to play roles in the cell's response to the …
Purinergic GPCR transmembrane residues involved in ligand recognition and dimerization
V Salmaso, S Jain, KA Jacobson - Methods in cell biology, 2021 - Elsevier
We compare the GPCR-ligand interactions and highlight important residues for recognition
in purinergic receptors—from both X-ray crystallographic and cryo-EM structures. These …
in purinergic receptors—from both X-ray crystallographic and cryo-EM structures. These …